The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis

BACKGROUND: Multiple sclerosis (MS) is an autoimmune demyelinating disorder of the central nervous system (CNS). Despite improvements of immunomodulatory therapies in relapsing–remitting MS, the pathomechanisms of progressive disease are poorly understood and therapeutically addressed to date. A pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Diebold, Martin, Derfuss, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407165/
https://www.ncbi.nlm.nih.gov/pubmed/30873219
http://dx.doi.org/10.1177/1756286419833574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407165/
https://www.ncbi.nlm.nih.gov/pubmed/30873219
http://dx.doi.org/10.1177/1756286419833574

Ejemplares similares